Cancer/Neuroscience: Treatment-Related Cognitive Impairment

Deadline
Multiple
OPPORTUNITY NO.
PAR-16-212
MECHANISM
R01
RESEARCH AREA(S)
SYNOPSIS

This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as “chemobrain.” A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

Deadlines:

• Pre-Application Submission: N/A
• Application Submission: 5:00 PM local time of applicant organization, 
Apr. 11, 2017; Oct. 10, 2017; Apr. 11, 2018; Oct. 10, 2018; Apr. 11, 2019

Companion Opportunity:

ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.